Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

China Antineoplastic Agents Market Report to 2021

  • QYR777623
  • 102 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Antineoplastic Agents

Revenue, means the sales value of Antineoplastic Agents

This report studies sales (consumption) of Antineoplastic Agents in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Novartis

Pfizer, Inc.

Roche

Sanofi

Merck & Co., Inc.

GlaxoSmithKline plc

Johnson & Johnson

AstraZeneca plc.

Eli Lilly and Company

Abbvie

AMGen

Teva Pharmaceutical Industries Ltd.

Bayer AG

Bristol-Myers Squibb

Astellas Pharma

Daiichi Sankyo

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Alkylating Agent

Anti-metabolic Tumor Drugs

Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives

Others

Split by applications, this report focuses on sales, market share and growth rate of Antineoplastic Agents in each application, can be divided into

First Level Hospital

Two Level Hospital

Three Level Hospital

Others

Table of Contents

China Antineoplastic Agents Market Report 2021

1 Antineoplastic Agents Overview

1.1 Product Overview and Scope of Antineoplastic Agents

1.2 Classification of Antineoplastic Agents

1.2.1 Alkylating Agent

1.2.2 Anti-metabolic Tumor Drugs

1.2.3 Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives

1.2.4 Others

1.3 Applications of Antineoplastic Agents

1.3.1 First Level Hospital

1.3.2 Two Level Hospital

1.3.3 Three Level Hospital

1.3.4 Others

1.4 China Market Size (Value and Volume) of Antineoplastic Agents (2011-2021)

1.4.1 China Antineoplastic Agents Sales, Revenue and Price (2011-2021)

1.4.2 China Antineoplastic Agents Sales and Growth Rate (2011-2021)

1.4.3 China Antineoplastic Agents Revenue and Growth Rate (2011-2021)

2 China Antineoplastic Agents Competition by Manufacturers

2.1 China Antineoplastic Agents Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 China Antineoplastic Agents Revenue and Share by Manufactures (2015 and 2016)

3 China Antineoplastic Agents (Volume and Value) by Type

3.1 China Antineoplastic Agents Sales and Market Share by Type (2011-2021)

3.2 China Antineoplastic Agents Revenue and Market Share by Type (2011-2021)

4 China Antineoplastic Agents (Volume) by Application

5 China Antineoplastic Agents Manufacturers Analysis

5.1 Novartis

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Antineoplastic Agents Product Type and Technology

5.1.2.1 Alkylating Agent

5.1.2.2 Anti-metabolic Tumor Drugs

5.1.3 Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)

5.2 Pfizer, Inc.

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Alkylating Agent

5.2.2.2 Anti-metabolic Tumor Drugs

5.2.3 Pharmaceuticals Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)

5.3 Roche

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Roche Product Type and Technology

5.3.2.1 Alkylating Agent

5.3.2.2 Anti-metabolic Tumor Drugs

5.3.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)

5.4 Sanofi

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 Eli Lilly and Company Product Type and Technology

5.4.2.1 Alkylating Agent

5.4.2.2 Anti-metabolic Tumor Drugs

5.4.3 Sanofi Sales, Revenue, Price of Sanofi (2015 and 2016)

5.5 Merck & Co., Inc.

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 Merck & Co., Inc. Product Type and Technology

5.5.2.1 Alkylating Agent

5.5.2.2 Anti-metabolic Tumor Drugs

5.5.3 Merck & Co., Inc. Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)

5.6 GlaxoSmithKline plc

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 GlaxoSmithKline plc Product Type and Technology

5.6.2.1 Alkylating Agent

5.6.2.2 Anti-metabolic Tumor Drugs

5.6.3 GlaxoSmithKline plc Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)

5.7 Johnson & Johnson

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Johnson & Johnson Product Type and Technology

5.7.2.1 Alkylating Agent

5.7.2.2 Anti-metabolic Tumor Drugs

5.7.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

5.8 AstraZeneca plc.

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 AstraZeneca plc. Product Type and Technology

5.8.2.1 Alkylating Agent

5.8.2.2 Anti-metabolic Tumor Drugs

5.8.3 AstraZeneca plc. Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)

5.9 Eli Lilly and Company

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 Eli Lilly and Company Product Type and Technology

5.9.2.1 Alkylating Agent

5.9.2.2 Anti-metabolic Tumor Drugs

5.9.3 Eli Lilly and Company Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)

5.10 Abbvie

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Abbvie Product Type and Technology

5.10.2.1 Alkylating Agent

5.10.2.2 Anti-metabolic Tumor Drugs

5.10.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)

5.11 AMGen

5.12 Teva Pharmaceutical Industries Ltd.

5.13 Bayer AG

5.14 Bristol-Myers Squibb

5.15 Astellas Pharma

5.16 Daiichi Sankyo

6 Antineoplastic Agents Technology and Development Trend

6.1 Antineoplastic Agents Technology Analysis

6.2 Antineoplastic Agents Technology Development Trend

7 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Antineoplastic Agents

Table Classification of Antineoplastic Agents

Figure China Sales Market Share of Antineoplastic Agents by Type in 2015

Figure Alkylating Agent Picture

Figure Anti-metabolic Tumor Drugs Picture

Figure Antineoplastic Natural Drugs and Their Semi - Synthetic Derivatives Picture

Figure Others Picture

Table Applications of Antineoplastic Agents

Figure China Sales Market Share of Antineoplastic Agents by Application in 2015

Figure First Level Hospital Examples

Figure Two Level Hospital Examples

Figure Three Level Hospital Examples

Figure Others Examples

Table China Antineoplastic Agents Sales, Revenue and Price (2011-2021)

Figure China Antineoplastic Agents Sales and Growth Rate (2011-2021)

Figure China Antineoplastic Agents Revenue and Growth Rate (2011-2021)

Table China Antineoplastic Agents Sales of Key Manufacturers (2015 and 2016)

Table China Antineoplastic Agents Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Antineoplastic Agents Sales Share by Manufacturers

Figure 2016 Antineoplastic Agents Sales Share by Manufacturers

Table China Antineoplastic Agents Revenue by Manufacturers (2015 and 2016)

Table China Antineoplastic Agents Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Antineoplastic Agents Revenue Share by Manufacturers

Table 2016 China Antineoplastic Agents Revenue Share by Manufacturers

Table China Antineoplastic Agents Sales and Market Share by Type (2011-2021)

Table China Antineoplastic Agents Sales Share by Type (2011-2021)

Figure Sales Market Share of Antineoplastic Agents by Type (2011-2021)

Figure China Antineoplastic Agents Sales Growth Rate by Type (2011-2021)

Table China Antineoplastic Agents Revenue and Market Share by Type (2011-2021)

Table China Antineoplastic Agents Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Antineoplastic Agents by Type (2011-2021)

Figure China Antineoplastic Agents Revenue Growth Rate by Type (2011-2021)

Table China Antineoplastic Agents Sales and Market Share by Application (2011-2021)

Table China Antineoplastic Agents Sales Share by Application (2011-2021)

Figure Sales Market Share of Antineoplastic Agents by Application (2011-2021)

Figure China Antineoplastic Agents Sales Growth Rate by Application (2011-2021)

Table Novartis Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Novartis (2015 and 2016)

Table Pfizer, Inc. Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)

Table Roche Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Roche (2015 and 2016)

Table Sanofi Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Sanofi (2015 and 2016)

Table Merck & Co., Inc. Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)

Table GlaxoSmithKline plc Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)

Table Johnson & Johnson Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)

Table AstraZeneca plc. Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)

Table Eli Lilly and Company Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)

Table Abbvie Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Abbvie (2015 and 2016)

Table AMGen Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of AMGen (2015 and 2016)

Table Teva Pharmaceutical Industries Ltd. Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)

Table Bayer AG Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Bayer AG (2015 and 2016)

Table Bristol-Myers Squibb Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)

Table Astellas Pharma Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Astellas Pharma (2015 and 2016)

Table Daiichi Sankyo Basic Information List

Table Antineoplastic Agents Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370